Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1966 1
1975 1
1976 1
1977 2
1978 2
1979 1
1980 5
1981 1
1982 5
1983 8
1984 5
1985 5
1986 2
1987 8
1988 11
1989 12
1990 17
1991 25
1992 22
1993 27
1994 15
1995 39
1996 29
1997 30
1998 38
1999 52
2000 59
2001 49
2002 44
2003 71
2004 66
2005 65
2006 71
2007 87
2008 102
2009 101
2010 120
2011 128
2012 163
2013 172
2014 160
2015 181
2016 181
2017 133
2018 142
2019 159
2020 175
2021 150
2022 140
2023 113
2024 49

Text availability

Article attribute

Article type

Publication date

Search Results

2,894 results

Results by year

Filters applied: . Clear all
Page 1
Survival Analysis of Glioblastoma Multiforme.
Witthayanuwat S, Pesee M, Supaadirek C, Supakalin N, Thamronganantasakul K, Krusun S. Witthayanuwat S, et al. Asian Pac J Cancer Prev. 2018 Sep 26;19(9):2613-2617. doi: 10.22034/APJCP.2018.19.9.2613. Asian Pac J Cancer Prev. 2018. PMID: 30256068 Free PMC article.
Introduction: To evaluate the survival of Glioblastoma Multiforme (GBM). Material and Methods: Patients with a pathological diagnosis of Glioblastoma Multiforme (GBM) between 1 January 1994 and 30 November 2013, were retrospectively reviewed. ...Conclu …
Introduction: To evaluate the survival of Glioblastoma Multiforme (GBM). Material and Methods: Patients with a pathological di …
Identification and validation of neurotrophic factor-related gene signatures in glioblastoma and Parkinson's disease.
Zhao S, Chi H, Yang Q, Chen S, Wu C, Lai G, Xu K, Su K, Luo H, Peng G, Xia Z, Cheng C, Lu P. Zhao S, et al. Front Immunol. 2023 Feb 7;14:1090040. doi: 10.3389/fimmu.2023.1090040. eCollection 2023. Front Immunol. 2023. PMID: 36825022 Free PMC article.
BACKGROUND: Glioblastoma multiforme (GBM) is the most common cancer of the central nervous system, while Parkinson's disease (PD) is a degenerative neurological condition frequently affecting the elderly. ...The nomogram generated based on clinical characteristics a …
BACKGROUND: Glioblastoma multiforme (GBM) is the most common cancer of the central nervous system, while Parkinson's disease ( …
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.
Roa W, Brasher PM, Bauman G, Anthes M, Bruera E, Chan A, Fisher B, Fulton D, Gulavita S, Hao C, Husain S, Murtha A, Petruk K, Stewart D, Tai P, Urtasun R, Cairncross JG, Forsyth P. Roa W, et al. J Clin Oncol. 2004 May 1;22(9):1583-8. doi: 10.1200/JCO.2004.06.082. Epub 2004 Mar 29. J Clin Oncol. 2004. PMID: 15051755 Clinical Trial.
PURPOSE: To prospectively compare standard radiation therapy (RT) with an abbreviated course of RT in older patients with glioblastoma multiforme (GBM). PATIENTS AND METHODS: One hundred patients with GBM, age 60 years or older, were randomly assigned after surgery …
PURPOSE: To prospectively compare standard radiation therapy (RT) with an abbreviated course of RT in older patients with glioblastoma …
Biomarkers of glioblastoma multiforme.
Nicolaidis S. Nicolaidis S. Metabolism. 2015 Mar;64(3 Suppl 1):S22-7. doi: 10.1016/j.metabol.2014.10.031. Epub 2014 Oct 30. Metabolism. 2015. PMID: 25468141 Review.
Glioblastoma multiforme (GBM) is the most common and lethal primary malignancy of the central nervous system. ...
Glioblastoma multiforme (GBM) is the most common and lethal primary malignancy of the central nervous system. ...
Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment.
Pearson JRD, Cuzzubbo S, McArthur S, Durrant LG, Adhikaree J, Tinsley CJ, Pockley AG, McArdle SEB. Pearson JRD, et al. Front Immunol. 2020 Oct 15;11:582106. doi: 10.3389/fimmu.2020.582106. eCollection 2020. Front Immunol. 2020. PMID: 33178210 Free PMC article. Review.
Glioblastoma multiforme (GBM) is the most frequently occurring primary brain tumor and has a very poor prognosis, with only around 5% of patients surviving for a period of 5 years or more after diagnosis. ...Although immunotherapy represents an attractive therapy mo …
Glioblastoma multiforme (GBM) is the most frequently occurring primary brain tumor and has a very poor prognosis, with only ar …
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme.
Tilak M, Holborn J, New LA, Lalonde J, Jones N. Tilak M, et al. Int J Mol Sci. 2021 Feb 12;22(4):1831. doi: 10.3390/ijms22041831. Int J Mol Sci. 2021. PMID: 33673213 Free PMC article. Review.
Glioblastoma multiforme (GBM) is amongst the deadliest of human cancers, with a median survival rate of just over one year following diagnosis. ...We also present a unique genomic survey of RTKs that are frequently altered in GBM subtypes, as well as catalog the GBM …
Glioblastoma multiforme (GBM) is amongst the deadliest of human cancers, with a median survival rate of just over one year fol …
Glioblastoma multiforme prognosis: MRI missing modality generation, segmentation and radiogenomic survival prediction.
Islam M, Wijethilake N, Ren H. Islam M, et al. Comput Med Imaging Graph. 2021 Jul;91:101906. doi: 10.1016/j.compmedimag.2021.101906. Epub 2021 May 5. Comput Med Imaging Graph. 2021. PMID: 34175548
The accurate prognosis of glioblastoma multiforme (GBM) plays an essential role in planning correlated surgeries and treatments. ...The proposed approaches are evaluated by comparative experiments with state-of-the-art models in synthesis, segmentation, and overall …
The accurate prognosis of glioblastoma multiforme (GBM) plays an essential role in planning correlated surgeries and treatment …
Nomograms for prognostic risk assessment in glioblastoma multiforme: Applications and limitations.
Zheng H, Yan T, Han Y, Wang Q, Zhang G, Zhang L, Zhu W, Xie L, Guo X. Zheng H, et al. Clin Genet. 2022 Nov;102(5):359-368. doi: 10.1111/cge.14200. Epub 2022 Aug 1. Clin Genet. 2022. PMID: 35882630 Review.
Glioblastoma multiforme (GBM) is the most common and aggressive form of brain cancer. ...By integrating different prognostic variables, nomograms simplify the statistical risk prediction model into numerical estimates for death or recurrence, and are hence wi …
Glioblastoma multiforme (GBM) is the most common and aggressive form of brain cancer. ...By integrating different prognostic v …
Expression and clinical significance of organic cation transporter family in glioblastoma multiforme.
Lian Q, Xiao S, Wang Y, Wang H, Xie D. Lian Q, et al. Ir J Med Sci. 2022 Jun;191(3):1115-1121. doi: 10.1007/s11845-021-02675-3. Epub 2021 Jun 2. Ir J Med Sci. 2022. PMID: 34080124
The expression of SLC22A1-A3 in cancer is seldom investigated, and the function of SLC22A1-A3 in glioblastoma multiforme (GBM) is never elucidated. MATERIALS: In our study, we detected the expression of SLC22A1-A3 in 11 fresh GBMs and tumor-adjacent brain tissues wi …
The expression of SLC22A1-A3 in cancer is seldom investigated, and the function of SLC22A1-A3 in glioblastoma multiforme (GBM) …
Re-Irradiation for Recurrent Glioblastoma Multiforme.
Rades D, Witteler J, Leppert J, Schild SE. Rades D, et al. Anticancer Res. 2020 Dec;40(12):7077-7081. doi: 10.21873/anticanres.14735. Anticancer Res. 2020. PMID: 33288605
BACKGROUND/AIM: Patients requiring re-irradiation for recurrent glioblastoma multiforme (GBM) may benefit from individualized therapy. This study aimed to identify predictors of survival and contribute to treatment personalization. ...
BACKGROUND/AIM: Patients requiring re-irradiation for recurrent glioblastoma multiforme (GBM) may benefit from individualized …
2,894 results